Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) Director Peter Thompson sold 875 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $44.49, for a total value of $38,928.75. Following the completion of the transaction, the director owned 3,595,011 shares of the company’s stock, […]

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) insider Jennifer Michaelson sold 2,898 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $9.67, for a total value of $28,023.66. Following the transaction, the insider directly owned 133,980 shares in the company, […]

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) insider Jennifer Michaelson sold 2,148 shares of Cullinan Therapeutics stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $12.38, for a total transaction of $26,592.24. Following the completion of the sale, the insider owned 137,873 shares in the company, […]

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 6,663 shares of Enliven Therapeutics stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $21.02, for a total value of $140,056.26. Following the sale, the chief operating officer directly owned 263,311 shares of the company’s […]

Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) CEO Michael Thomas Henderson sold 40,000 shares of the firm’s stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $75.01, for a total value of $3,000,400.00. Following the transaction, the chief executive officer directly owned 1,232,987 shares of the […]